Safety and Effectiveness of Once-Daily Tadalafil (5 mg) Therapy in Korean Men with Benign Prostatic Hyperplasia/Lower Urinary Tract Symptoms in a Real-World Clinical Setting: Results from a Post-Marketing Surveillance Study.

Won, Ji Eon; Chu, Ji Yeon; Choi, Hyunah Caroline; Chen, Yun; Park, Hyun Jun; Dueñas, Héctor José

Won, Ji Eon; Chu, Ji Yeon; Choi, Hyunah Caroline; Chen, Yun; Park, Hyun Jun; Dueñas, Héctor José.

Afiliación

Won JE; Lilly Korea, Seoul, South Korea.
Chu JY; Lilly Korea, Seoul, South Korea.
Choi HC; Lilly Korea, Seoul, South Korea.
Chen Y; Lilly Suzhou Pharmaceutical Company, Shanghai, China.
Park HJ; Department of Urology, Pusan National University School of Medicine, Busan, Korea. joon501@naver.com.
Dueñas HJ; Eli Lilly de Mexico, Mexico City, Mexico.

World J Mens Health ; 36(2): 161-170, 2018 May.

Article en En | MEDLINE | ID: mdl-28879692

Palabras clave

Lower urinary tract symptoms; Phosphodiesterase 5 Inhibitors; Prostatic hyperplasia; Safety; Tadalafil

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Diagnostic_studies / Observational_studies / Screening_studies Aspecto: Patient_preference Idioma: En Revista: World J Mens Health Año: 2018 Tipo del documento: Article País de afiliación: Corea del Sur Pais de publicación:

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google